DoW Pancreatic Cancer Research Program, Focused Pilot Award | HT942526PCARPFPTA

FY26 DoD Pancreatic Cancer Research Program (PCARP) Focused Pilot Award - FAQs

What is the FY26 PCARP Focused Pilot Award?

The FY26 Department of Defense Pancreatic Cancer Research Program (PCARP) Focused Pilot Award is a grant opportunity designed to jump-start early-stage, high-impact pancreatic cancer research ideas. It prioritizes projects that are strongly patient-centered and aimed at meaningfully improving patients overall quality of life.

What is the main purpose of this award mechanism?

The purpose is to help investigators quickly and credibly test innovative concepts so they can generate solid preliminary evidence. The expectation is that the pilot results will position the project for a realistic next step, such as follow-on clinical research or real-world application.

What kinds of outcomes is the program expecting from a funded pilot?

Projects should be designed to produce robust, decision-quality pilot data with clear outcomes and actionable next steps. The award is meant to support work that makes a later-phase study or broader translational effort feasible and well-justified.

What types of research activities does this award support?

Based on the description provided, the award supports focused efforts such as testing a specific hypothesis, establishing feasibility, developing enabling datasets, or validating an approach. The emphasis is on work that can be explored quickly while still generating credible evidence.

Is preliminary data required to apply?

No. Applicants are allowed to include preliminary results, but they are not required to have them. This flexibility is intended to make the award suitable for new directions, emerging methods, or novel patient-centered approaches with strong rationale but limited existing data.

If preliminary data is not required, what will reviewers look for instead?

The research still needs to be designed to produce robust pilot evidence rather than purely exploratory observations. Reviewers will generally be looking for a tight, well-justified plan that can yield clear outcomes within the pilot scope and support a credible go/no-go decision for the next step.

Does this opportunity allow clinical research?

Yes. The opportunity can support clinical research studies, meaning studies involving people may be possible as long as they fit the definition of clinical research under the solicitation.

Are clinical trials allowed under this mechanism?

No. The program explicitly does not permit clinical trials under this award mechanism. Projects must be structured so they do not cross into a clinical trial framework.

Are animal studies allowed or competitive under this award?

The program states that preclinical animal studies do not meet the intent of this award. This signals that proposals centered on animal models are unlikely to be considered responsive or competitive for this mechanism.

What does "patient-centered" mean in the context of this opportunity?

From the provided description, the patient-centered emphasis means the research should be aimed at meaningfully improving pancreatic cancer patients overall quality of life and generating results that can move toward clinical or practical use. The program is prioritizing ideas with a clear connection to patient impact.

How many awards does the sponsor expect to make?

The anticipated number of awards is four.

Who is the sponsoring agency for this grant?

The sponsor is the Department of the Army, U.S. Army Medical Research Acquisition Activity (USAMRAA), under the Department of Defense Pancreatic Cancer Research Program (PCARP).

What is the assistance listing / CFDA number and category shown for this opportunity?

The listing is shown as CFDA 12.420 and is categorized under Science and Technology and other Research and Development. It is listed as a discretionary grant.

Who is eligible to apply?

Eligibility is listed as unrestricted. This generally indicates a broad applicant pool may apply, subject to the full solicitation terms and requirements.

What is the application deadline?

The posted application closing date is October 7, 2026.

What is the maximum budget (award ceiling) for this opportunity?

The provided information indicates an award ceiling field exists, but it does not include a dollar amount. Applicants would need to consult the full solicitation and/or the Grants.gov posting to confirm budget limits, allowable costs, and other financial rules.

Where can applicants find the full details on allowable costs and project period?

The provided description notes that applicants should consult the full solicitation or the Grants.gov posting for budget limits, allowable costs, and period of performance details.

What is the intended timeline and scope of a "focused pilot" in this program?

The mechanism is intended for concepts that can be explored quickly and credibly enough to produce solid preliminary evidence within a pilot scope. The project plan should be focused and designed to generate clear results that support a realistic follow-on effort.

What should applicants keep in mind about responsiveness to the program intent?

Based on the description provided, applicants should ensure the core work is patient-centered and quality-of-life focused, avoids clinical trials, and does not rely on preclinical animal studies as the central approach. The project should be structured to generate robust pilot evidence that enables the next translational or clinical step.